#USA #Los Angeles #skinbetter science #AlphaRet #Retinoid Research

Skinbetter Science Revolutionizes Retinoid Science

This week, skinbetter science is spearheading the conversation around retinoids as it celebrates the third annual National Retinoid Week. With a reputation as the leading dermatologist-recommended retinoid brand, the company has unveiled compelling new clinical findings that reinforce its commitment to advancing retinoid science, innovation, and consumer education.

National Retinoid Week was initiated by skinbetter science to foster informed discussions about the use of retinoids. The celebration highlights the brand's ongoing mission to empower consumers by providing expert-backed education and effective solutions for incorporating retinoids into their skincare routines. This year's festivities are particularly notable as they follow the 10-year anniversary of the brand's award-winning AlphaRet Technology. The new research underscores the efficacy of this technology, delivering visible skincare results while maintaining high tolerability levels for users.

Results from a recent study were groundbreaking. An impressive 98% of participants who identified as retinoid-sensitive reported that they could comfortably use AlphaRet Overnight Cream nightly, showcasing the product's suitability for even those with challenging skin conditions. In accordance with the data obtained from the 12-week clinical study of patients with retinoid intolerance, the key findings include:

• - 98% of users confirmed the suitability of AlphaRet Overnight Cream for nighttime use.
• - 95% reported improvements in skin smoothness, firmness, and comfort.
• - 42% enhancement in skin hydration observed at the end of the 12-week period.
• - 48% reduction in skin dullness noted within the same timeframe.

Geneviève Bibeau, the General Manager of skinbetter science USA, reflected on the significance of their work during this pivotal week: "As we commemorate our third National Retinoid Week, our mission to advance the retinoid category continues. We strive to equip more consumers with the knowledge to integrate retinoids into their skin care routines with confidence."

She further emphasized, "At skinbetter science, we hold a firm belief that consumers should not have to compromise between efficacy and tolerability. AlphaRet was designed to challenge that compromise, offering prescription-strength effectiveness alongside outstanding tolerability. National Retinoid Week presents an invaluable opportunity to translate our scientific breakthroughs into accessible education via dermatologist-led initiatives, expert partnerships, and engaging social media content aimed at connecting consumers with credible information. This assists them in making more informed decisions tailored to their skin needs."

Dr. Annie Gonzalez, a board-certified dermatologist and founder of Glösense Dermatology Aesthetics who partnered with skinbetter, shared her insights on the study, emphasizing the importance of the patient demographics who participated. She stated, "What stood out most in this study was not just the efficacy data but the profiles of the participants—those who identified as retinoid-intolerant. Many of them had previously tried and failed with other retinoids, yet skinbetter science recorded remarkably high tolerability levels over 12 weeks. That speaks volumes about AlphaRet’s potential!"

As part of the initiatives for National Retinoid Week, skinbetter science is committed to improving consumer education. This is being realized through dermatologist-led informational content and interactive social media activities. Additionally, the brand is rolling out exclusive gifts and promotional offers via their website, skinbetter.com, allowing consumers to explore the AlphaRet Collection and other products. These offerings are accessible exclusively through authorized physician providers or directly on the brand’s website.

In conclusion, skinbetter science continues to establish itself as a frontrunner in skincare innovation. The company was founded in 2016 with the goal of developing skincare driven by science, care, and visible results. Their ongoing investments in clinical validation of safety and efficacy have built a reputable presence alongside partners such as dermatologists and plastic surgeons across the aesthetic medical community. Consumers wishing to learn more about skinbetter science or locate an authorized physician can do so at their website.

Study Details: This particular investigation was a 12-week, multicenter, dermatologist-led clinical study assessing the nightly use of AlphaRet Overnight Cream in participants identifying with retinoid sensitivity and mild-to-moderate signs of photoaging. Sample size (N=56).